Cargando…
An in vitro model of tumor heterogeneity resolves genetic, epigenetic, and stochastic sources of cell state variability
Tumor heterogeneity is a primary cause of treatment failure and acquired resistance in cancer patients. Even in cancers driven by a single mutated oncogene, variability in response to targeted therapies is well known. The existence of additional genomic alterations among tumor cells can only partial...
Autores principales: | Hayford, Corey E., Tyson, Darren R., Robbins, C. Jack, Frick, Peter L., Quaranta, Vito, Harris, Leonard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195356/ https://www.ncbi.nlm.nih.gov/pubmed/34061819 http://dx.doi.org/10.1371/journal.pbio.3000797 |
Ejemplares similares
-
An unbiased metric of antiproliferative drug effect in vitro
por: Harris, Leonard A., et al.
Publicado: (2016) -
A drift-diffusion checkpoint model predicts a highly variable and growth-factor-sensitive portion of the cell cycle G1 phase
por: Jones, Zack W., et al.
Publicado: (2018) -
Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines
por: Wandishin, Clayton M., et al.
Publicado: (2022) -
Fractional Proliferation: A method to deconvolve cell population dynamics from single-cell data
por: Tyson, Darren R., et al.
Publicado: (2012) -
Thunor: visualization and analysis of high-throughput dose–response datasets
por: Lubbock, Alexander L R, et al.
Publicado: (2021)